GlaxoSmithKline Plc

$42.03
GSK - NYSE
Dividend yield
Dividend has grown by 0.22% in last three years.
4.49 %
$2.026 anually
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
GlaxoSmithKline Plc last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile GSK stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt GlaxoSmithKline Plc have in comparison to other dividend stocks
Become our supporter to unlock all data!
GlaxoSmithKline Plc description

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Company profile
Market cap
Mega (104.67B)
Company CEO
Emma Walmsley
Price history GlaxoSmithKline Plc
Loading price stock history...
GSK dividends payouts
Similar stocks as GlaxoSmithKline Plc